IP Library Granted Patent US 9,724,242
Granted Patent B2
US 9,724,242 · App. 14/225,268 · Granted Aug 8, 2017

Devices for protecting vulnerable sites on patients from liquid contamination and related devices, systems, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,724,242
App. No.
14/225,268
Granted
Aug 8, 2017
Kind
B2
Abstract

A protective device configured in accordance with a particular embodiment includes a cover including a first region that extends over a vulnerable site on a patient and a second region that extends over an area on the patient peripheral to the vulnerable site. The first region of the cover is at least generally impermeable to liquid water. The device further includes an adhesive film and a liquid-absorbing element. The adhesive film is configured to form an adhesive bond between the second region of the cover and the patient. The bond has an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site. The liquid-absorbing element is configured to absorb liquid contamination at the outer edge portion of the bond and/or liquid contamination approaching the outer edge portion of the bond when the cover is operably positioned on the patient.

Claims (14)

1. A protective method, comprising:

positioning a first region of a cover over a vulnerable site on a human patient, the first region of the cover being at least generally impermeable to liquid water;

positioning a second region of the cover between the vulnerable site and the patient's mouth and/or nose;

forming an adhesive bond between the second region of the cover and the patient, the bond having an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site;

absorbing respiratory exudates from the patient's mouth and/or nose at the outer edge portion of the bond and/or respiratory exudates approaching the outer edge portion of the bond using a liquid-absorbing element attached to the cover; and

at least generally blocking direct exchange between air in contact with the vulnerable site at one side of the bond and air in contact with respiratory exudates within the liquid-absorbing element at an opposite side of the bond.

2. The protective method of claim 1 wherein positioning the first region of the cover over the vulnerable site includes positioning the first region of the cover over a vulnerable site at least proximate to the patient's neck.

3. The protective method of claim 1 wherein positioning the first region of the cover over the vulnerable site includes positioning the first region of the cover over a percutaneous device at the vulnerable site.

4. The protective method of claim 1 , further comprising moving the first region of the cover to at least partially expose the vulnerable site without disrupting the bond.

5. The protective method of claim 1 , further comprising visually monitoring the vulnerable site through the first region of the cover.

6. The protective method of claim 1 wherein:

forming the bond includes forming the bond around from about 10% to about 90% of a perimeter of the first region of the cover; and

the method further comprises ventilating the vulnerable site through a gap between the patient and a third region of the cover at a portion of the perimeter of the first region of the cover around which the bond is not formed.

7. The protective method of claim 1 wherein absorbing respiratory exudates includes wicking respiratory exudates away from the outer edge portion of the bond.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS THE AGENT
To: TIDI AQUAGUARD OPERATIONS LLC (FORMERLY KNOWN AS TIDI AQUAGUARD OPERATIONS INC., FORMERLY KNOWN AS COVALON TECHNOLOGIES AG LTD.)
Reel/Frame 066079/0760 →
SECURITY INTEREST Recorded Dec 27, 2023
From: TIDI PRODUCTS, LLC; PENBLADE, LLC
To: ADAMS STREET CREDIT ADVISORS LP, AS COLLATERAL AGENT
Reel/Frame 066126/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2022
From: TIDI AQUAGUARD OPERATIONS, LLC
To: TIDI PRODUCTS, LLC
Reel/Frame 059794/0422 →
ENTITY CONVERSION Recorded Jan 4, 2022
From: TIDI AQUAGUARD OPERATIONS INC.
To: TIDI AQUAGUARD OPERATIONS LLC
Reel/Frame 058575/0341 →
SECURITY INTEREST Recorded Aug 18, 2021
From: TIDI AQUAGUARD OPERATIONS INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 057217/0270 →
CHANGE OF NAME Recorded Aug 11, 2021
From: COVALON TECHNOLOGIES AG LTD.
To: TIDI AQUAGUARD OPERATIONS INC.
Reel/Frame 057177/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2019
From: CENORIN, LLC
To: COVALON TECHNOLOGIES AG LTD.
Reel/Frame 048031/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: CENORIN, LLC
To: COVALON TECHNOLOGIES AG LTD.
Reel/Frame 047711/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2015
From: SEGUIN, ART; ARAMBULA, GERRY
To: CENORIN, LLC
Reel/Frame 034988/0373 →